Pinnacle Associates’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$48.1K Sell
50,815
-3,365
-6% -$3.18K ﹤0.01% 842
2025
Q1
$25K Sell
54,180
-1,371,112
-96% -$632K ﹤0.01% 819
2024
Q4
$1.05M Sell
1,425,292
-305,529
-18% -$226K 0.01% 478
2024
Q3
$2.65M Buy
1,730,821
+14,990
+0.9% +$22.9K 0.05% 318
2024
Q2
$2.88M Sell
1,715,831
-31,999
-2% -$53.8K 0.05% 307
2024
Q1
$4.19M Buy
1,747,830
+17,009
+1% +$40.8K 0.07% 266
2023
Q4
$2.65M Sell
1,730,821
-182,048
-10% -$279K 0.04% 322
2023
Q3
$2.09M Sell
1,912,869
-80,758
-4% -$88K 0.04% 349
2023
Q2
$4.57M Buy
1,993,627
+53,403
+3% +$122K 0.08% 243
2023
Q1
$4.71M Buy
1,940,224
+7,447
+0.4% +$18.1K 0.1% 212
2022
Q4
$3.69M Sell
1,932,777
-98,430
-5% -$188K 0.08% 229
2022
Q3
$4.88M Sell
2,031,207
-56,256
-3% -$135K 0.11% 200
2022
Q2
$3.88M Sell
2,087,463
-6,831
-0.3% -$12.7K 0.08% 228
2022
Q1
$4.38M Sell
2,094,294
-33,368
-2% -$69.7K 0.08% 238
2021
Q4
$8.38M Buy
2,127,662
+30,015
+1% +$118K 0.14% 164
2021
Q3
$10.1M Sell
2,097,647
-93,135
-4% -$448K 0.19% 139
2021
Q2
$10.1M Buy
2,190,782
+23,610
+1% +$108K 0.18% 142
2021
Q1
$12.7M Buy
2,167,172
+314,790
+17% +$1.85M 0.24% 118
2020
Q4
$6.34M Buy
1,852,382
+1,505,122
+433% +$5.15M 0.13% 174
2020
Q3
$500K Sell
347,260
-11,250
-3% -$16.2K 0.01% 487
2020
Q2
$715K Buy
358,510
+2,165
+0.6% +$4.32K 0.02% 427
2020
Q1
$695K Sell
356,345
-43,029
-11% -$83.9K 0.02% 398
2019
Q4
$1.66M Sell
399,374
-71,975
-15% -$299K 0.04% 329
2019
Q3
$1.42M Sell
471,349
-39,485
-8% -$119K 0.03% 349
2019
Q2
$3.21M Sell
510,834
-39,715
-7% -$250K 0.08% 251
2019
Q1
$3.06M Buy
550,549
+9,615
+2% +$53.5K 0.07% 255
2018
Q4
$3.59M Sell
540,934
-37,785
-7% -$251K 0.09% 232
2018
Q3
$6.18M Sell
578,719
-96,106
-14% -$1.03M 0.13% 185
2018
Q2
$8.1M Sell
674,825
-115,860
-15% -$1.39M 0.17% 160
2018
Q1
$6.78M Sell
790,685
-63,490
-7% -$544K 0.13% 179
2017
Q4
$8.44M Sell
854,175
-42,870
-5% -$424K 0.16% 158
2017
Q3
$11M Buy
897,045
+182,215
+25% +$2.24M 0.2% 120
2017
Q2
$11.8M Buy
+714,830
New +$11.8M 0.23% 112